Ad is loading...
PGEN
Price
$0.82
Change
-$0.06 (-6.82%)
Updated
Nov 15 closing price
101 days until earnings call
RCKT
Price
$13.98
Change
-$0.84 (-5.67%)
Updated
Nov 15 closing price
109 days until earnings call
Ad is loading...

PGEN vs RCKT

Header iconPGEN vs RCKT Comparison
Open Charts PGEN vs RCKTBanner chart's image
Precigen
Price$0.82
Change-$0.06 (-6.82%)
Volume$1.78M
CapitalizationN/A
Rocket Pharmaceuticals
Price$13.98
Change-$0.84 (-5.67%)
Volume$1.13M
CapitalizationN/A
PGEN vs RCKT Comparison Chart
Loading...
PGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
PGEN vs. RCKT commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGEN is a Hold and RCKT is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (PGEN: $0.82 vs. RCKT: $13.98)
Brand notoriety: PGEN and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PGEN: 236% vs. RCKT: 124%
Market capitalization -- PGEN: $240M vs. RCKT: $1.27B
PGEN [@Biotechnology] is valued at $240M. RCKT’s [@Biotechnology] market capitalization is $1.27B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PGEN’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 0 green FA rating(s).

  • PGEN’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 0 green, 5 red.
According to our system of comparison, RCKT is a better buy in the long-term than PGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PGEN’s TA Score shows that 4 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • PGEN’s TA Score: 4 bullish, 5 bearish.
  • RCKT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both PGEN and RCKT are a bad buy in the short-term.

Price Growth

PGEN (@Biotechnology) experienced а -15.96% price change this week, while RCKT (@Biotechnology) price change was -19.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

PGEN is expected to report earnings on Feb 26, 2025.

RCKT is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($1.27B) has a higher market cap than PGEN($240M). PGEN YTD gains are higher at: -38.799 vs. RCKT (-53.353). PGEN has higher annual earnings (EBITDA): -130.97M vs. RCKT (-243.06M). RCKT has more cash in the bank: 279M vs. PGEN (19.5M). PGEN has less debt than RCKT: PGEN (6.34M) vs RCKT (25.8M). PGEN has higher revenues than RCKT: PGEN (4.39M) vs RCKT (0).
PGENRCKTPGEN / RCKT
Capitalization240M1.27B19%
EBITDA-130.97M-243.06M54%
Gain YTD-38.799-53.35373%
P/E RatioN/AN/A-
Revenue4.39M0-
Total Cash19.5M279M7%
Total Debt6.34M25.8M25%
FUNDAMENTALS RATINGS
PGEN vs RCKT: Fundamental Ratings
PGEN
RCKT
OUTLOOK RATING
1..100
1760
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
45
Fair valued
PROFIT vs RISK RATING
1..100
10096
SMR RATING
1..100
9796
PRICE GROWTH RATING
1..100
8589
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (45) in the Biotechnology industry is in the same range as PGEN (58) in the null industry. This means that RCKT’s stock grew similarly to PGEN’s over the last 12 months.

RCKT's Profit vs Risk Rating (96) in the Biotechnology industry is in the same range as PGEN (100) in the null industry. This means that RCKT’s stock grew similarly to PGEN’s over the last 12 months.

RCKT's SMR Rating (96) in the Biotechnology industry is in the same range as PGEN (97) in the null industry. This means that RCKT’s stock grew similarly to PGEN’s over the last 12 months.

PGEN's Price Growth Rating (85) in the null industry is in the same range as RCKT (89) in the Biotechnology industry. This means that PGEN’s stock grew similarly to RCKT’s over the last 12 months.

PGEN's P/E Growth Rating (100) in the null industry is in the same range as RCKT (100) in the Biotechnology industry. This means that PGEN’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PGENRCKT
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
70%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 12 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
68%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Ad is loading...
PGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PKSAX56.79-0.32
-0.56%
Virtus KAR Small-Cap Core A
JASCX42.27-0.40
-0.94%
James Small Cap
GWGZX19.71-0.29
-1.45%
AMG GW&K Small Mid Cap Core Z
LSGRX30.23-0.51
-1.66%
Loomis Sayles Growth Y
THCRX30.03-0.65
-2.12%
Thornburg Small/Mid Cap Growth R3

PGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PGEN has been loosely correlated with CRSP. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PGEN jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PGEN
1D Price
Change %
PGEN100%
-7.11%
CRSP - PGEN
57%
Loosely correlated
+0.85%
BEAM - PGEN
55%
Loosely correlated
-8.59%
NTLA - PGEN
55%
Loosely correlated
-7.61%
RCKT - PGEN
53%
Loosely correlated
-5.67%
DNLI - PGEN
52%
Loosely correlated
-11.95%
More